rheumatoid arthritis

No surprise: AbbVie turns cold shoulder to a messy rheumatoid arthritis partnership with Ablynx
Endpoints
Thu, 10/20/16 - 09:34 am
AbbVie
rheumatoid arthritis
Ablynx
vobarilizumab
J&J optimistic in spite of biosimilar threat
BioPharma Dive
Wed, 10/19/16 - 10:39 am
JNJ
biosimilars
Remicade
Pfizer
rheumatoid arthritis
Pfizer set to start shipping Remicade biosimilar next month
Yahoo/Reuters
Tue, 10/18/16 - 12:03 am
Pfizer
Remicade
biosimilars
Inflectra
JNJ
rheumatoid arthritis
Could J&J's recent news about its rheumatoid arthritis and Crohn's disease drugs threaten AbbVie's Humira?
Motley Fool
Thu, 10/13/16 - 11:18 am
JNJ
rheumatoid arthritis
Crohn's Disease
AbbVie
Humira
sirukumab
​FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme
Bizjournals.com
Mon, 09/26/16 - 09:45 am
FDA
Sanofi Genzyme
Regeneron
Sarilumab
dupilumab
eczema
rheumatoid arthritis
FDA approves Amgen's copy of AbbVie arthritis drug Humira
Yahoo/Reuters
Fri, 09/23/16 - 10:24 pm
FDA
Amgen
Humira
rheumatoid arthritis
AbbVie
biosimilars
Novartis preps Zykadia for a frontline NSCLC pitch, but faces a tough rival in Roche; J&J, GSK hustle RA drug sirukumab to the FDA
Endpoints
Fri, 09/23/16 - 11:47 am
Novartis
Zykadia
non-small cell lung cancer
Roche
JNJ
GSK
rheumatoid arthritis
sirukumab
J&J, GSK advance their PhIII IL-6 rheumatoid arthritis drug down to a busy red zone
Endpoints
Tue, 09/13/16 - 10:06 am
JNJ
GSK
rheumatoid arthritis
sirukumab
FDA
Europe
Will Sales of Xeljanz Offset Falling Sales of Enbrel?
Market Realist
Tue, 09/6/16 - 09:47 am
Pfizer
Xeljanz
Enbrel
rheumatoid arthritis
JAK inhibitors
Novartis wins US OK for biosimilar version of Amgen's Enbrel
Yahoo/AP
Wed, 08/31/16 - 09:27 am
Novartis
biosimilars
Amgen
Enbrel
rheumatoid arthritis
Erelzi
Gilead tackles a big PhIII program for blockbuster hopeful filgotinib
Endpoints
Tue, 08/23/16 - 05:45 pm
Gilead Sciences
filgotinib
rheumatoid arthritis
Deutsche Takes A Look At Johnson & Johnson's Patent Woes
Yahoo/Benzinga
Fri, 08/19/16 - 11:34 am
JNJ
patents
Remicade
Pfizer
biosimilars
rheumatoid arthritis
Will AbbVie bite? Decision time after Ablynx’s rheumatoid arthritis drug fails a key study
Endpoints
Tue, 08/9/16 - 10:46 pm
Ablynx
AbbVie
rheumatoid arthritis
vobarilizumab
AbbVie Sues Amgen to Fend Off Copy of Blockbuster Humira
Yahoo/Bloomberg
Sat, 08/6/16 - 12:53 pm
AbbVie
Amgen
Humira
generics
biosimilars
rheumatoid arthritis
Amgen drug appears 'highly similar' to Humira -FDA staff
Yahoo/Reuters
Fri, 07/8/16 - 10:23 am
Amgen
Humira
FDA
Enbrel
rheumatoid arthritis
ABP 501
biosimilars
Will the approval of Inflectra be a biosimilar adoption tipping point?
BioPharma Dive
Fri, 06/10/16 - 10:18 am
Inflectra
biosimilars
Celltrion
Remicade
JNJ
rheumatoid arthritis
Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs
Yahoo
Thu, 06/9/16 - 10:10 am
baricitinib
Eli Lilly
Incyte
rheumatoid arthritis
J&J, GSK rheumatoid arthritis drug meets goals of large trial
Yahoo/Reuters
Wed, 06/8/16 - 10:06 am
JNJ
GSK
rheumatoid arthritis
clinical trials
sirukumab
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Yahoo/Reuters
Mon, 05/23/16 - 09:41 pm
Samsung Bioepis
Remicade
biosimilars
FDA
rheumatoid arthritis
JNJ
AbbVie Slides as U.S. Agency Questions Humira Patent
Bloomberg
Tue, 05/17/16 - 12:07 pm
AbbVie
Humira
patents
Coherus Biosciences
rheumatoid arthritis

Pages